Art

J-GLOBAL ID：201902249065311282   Reference number：19A2747727

Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis

白金耐性転移性尿路上皮癌患者におけるプログラム死-1またはプログラム死リガンド-1遮断:系統的レビューとMeta-分析【JST・京大機械翻訳】

Author (16)： Niglio Scot A. (Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Jia Rachel (Institute for Health Care Delivery Science, Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Ji Jiayi (Institute for Health Care Delivery Science, Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Ruder Samuel (Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Patel Vaibhav G. (Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Martini Alberto (Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Sfakianos John P. (Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Marqueen Kathryn E. (Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Waingankar Nikhil (Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Mehrazin Reza (Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Wiklund Peter (Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Wiklund Peter (Urology, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden) ,  Oh William K. (Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Mazumdar Madhu (Institute for Health Care Delivery Science, Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Ferket Bart S. (Institute for Health Care Delivery Science, Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) ,  Galsky Matthew D. (Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA)
Material： European Urology  (Eur Urol)
Volume： 76  Issue： 6  Page： 782-789  Publication year： 2019 
JST Material Number： A0910B  ISSN： 0302-2838  CODEN： EUURAV  Document type： Article
Article type： 文献レビュー  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Several anti-programmed death-...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2747727&from=J-GLOBAL&jstjournalNo=A0910B") }}

Thesaurus term： algorithm ,  drug therapy ,  confidence interval ,  randomized controlled trial ,  follow-up study ,  *platinum ,  reconstitution ,  *death ,  *human(primates) ,  antibody ,  bladder tumor
Semi thesaurus term： 阻害剤 ,  CD274抗原 ,  プログラム細胞死1受容体 ,  *遮断 ,  *転移性 , 【Automatic Indexing@JST】

Author keywords (6)： Bladder cancer ,  Immune checkpoint blockade ,  Meta-analysis ,  Programmed death-1 blockade ,  Programmed death ligand-1 blockade ,  Urothelial cancer

JST classification (1)： Urogenital tumors(=neoplasms)  (GM04000S)

Terms in the title (8)： 白金 ,  耐性 ,  転移性尿路上皮癌 ,  患者 ,  リガンド ,  遮断 ,  系統的レビュー ,  分析